Dr. David Clarke, president of the Association for the Treatment of Neuroplastic Symptoms, has launched a podcast series that examines the underlying causes of chronic pain and illness when no physical disease or injury can be identified. The podcast, titled "The Story Behind the Symptoms," represents the first series featuring a physician publicly interviewing patients to unravel the processes behind neuroplastic pain and illness.
Neuroplastic symptoms encompass chronic primary pain throughout the body, migraines, fibromyalgia, irritable bowel syndrome, post-viral syndromes, and numerous other conditions. These symptoms originate from pathways in the brain and nervous system that develop in response to stress, trauma, and adversity, frequently beginning in childhood. An estimated 1.5 billion people worldwide experience neuroplastic pain or illness, affecting four out of every ten patients seen by physicians.
The Association for the Treatment of Neuroplastic Symptoms, a 501(c)(3) nonprofit organization, advocates for an evidence-based, biopsychosocial approach known as Neuroplastic Recovery Therapy. This treatment method focuses on uncovering stress, trauma, and unrecognized emotions, enabling patients to manage their symptoms without relying on medications, surgical interventions, or costly treatments. Dr. Clarke emphasizes that Neuroplastic Recovery Therapy stands as the only treatment supported by gold standard scientific research from randomized trials published in leading medical journals, including the American Medical Association Psychiatry journal.
Listeners can access podcast episodes through the organization's website at https://symptomatic.me/podcast. The association recently commissioned the first national survey on neuroplastic pain and illness, with complete results scheduled for presentation at the ATNS 2025 National Conference from September 28-30 in Boulder, Colorado.
The podcast's approach to understanding and treating neuroplastic conditions offers significant implications for healthcare systems and patients worldwide. By addressing the root psychological and emotional factors contributing to chronic pain, this methodology provides a safer, more affordable, and potentially more effective alternative to traditional medical interventions. The widespread prevalence of neuroplastic symptoms suggests that improved awareness and treatment approaches could substantially reduce healthcare costs and improve quality of life for millions affected by these conditions.
